Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
2-phosphosulfolactate phosphatase is a Mg2+-dependent enzyme belonging to the hydrolase family, specifically acting on phosphoric monoester bonds (EC 3.1.3.71). It catalyzes the hydrolysis of (2R)-2-phospho-3-sulfolactate to produce (2R)-3-sulfolactate and phosphate. This enzyme is essential in the biosynthetic pathway for coenzyme M, the terminal methyl carrier in methanogenesis, particularly in methanogenic archaea such as Methanococcus jannaschii. The enzyme (also known as ComB phosphatase) is highly specific for 2-hydroxycarboxylic acid phosphate esters, requires Mg2+ for activity, exhibits a low pH optimum, and is thermostable. Homologs exist across cyanobacteria, bacteria, and archaea, often repurposed into various metabolic pathways. There is currently no clear evidence this enzyme serves as a direct therapeutic target or has characterized drug interactions or safety concerns in humans.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 2-phosphosulfolactate phosphatase.